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Introduction: Risk stratification in cardiac surgery significantly impacts outcome. This study seeks to define whether
there is an independent association between the preoperative serum level of hemoglobin (Hb), leukocyte count
(LEUCO), high sensitivity C-reactive protein (hsCRP), or B-type natriuretic peptide (BNP) and postoperative morbidity
and mortality in cardiac surgery.
Methods: Prospective, analytic cohort study, with 554 adult patients undergoing cardiac surgery in a tertiary
cardiovascular hospital and followed up for 12 months. The cohort was distributed according to preoperative values
of Hb, LEUCO, hsCRP, and BNP in independent quintiles for each of these variables.
Results: After adjustment for all covariates, a significant association was found between elevated preoperative BNP
and the occurrence of low postoperative cardiac output (OR 3.46, 95% CI 1.53–7.80, p = 0.003) or postoperative
atrial fibrillation (OR 3.8, 95% CI 1.45–10.38). For the combined outcome (death/acute coronary syndrome/
rehospitalization within 12 months), we observed an OR of 1.93 (95% CI 1.00–3.74). An interaction was found
between BNP level and the presence or absence of diabetes mellitus. The OR for non-diabetics was 1.26 (95% CI
0.61–2.60) and for diabetics was 18.82 (95% CI 16.2–20.5). Preoperative Hb was also significantly and independently
associated with the occurrence of postoperative low cardiac output (OR 0.33, 95% CI 0.13–0.81, p = 0.016). Both Hb
and BNP were significantly associated with the lengths of intensive care unit and hospital stays and the number of
transfused red blood cells (p < 0.002). Inflammatory markers, although associated with adverse outcomes, lost
statistical significance when adjusted for covariates.
Conclusions: High preoperative BNP or low Hb shows an association of independent risk with postoperative
outcomes, and their measurement could help to stratify surgical risk. The ability to predict the onset of atrial
fibrillation or postoperative low cardiac output has important clinical implications. Our results open the possibility of
designing studies that incorporate BNP measurement as a routine part of preoperative evaluation, and this strategy
could improve upon the standard evaluation in terms of reducing adverse postoperative events.
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Cardiac surgery is associated with significant risk of
morbidity and mortality. In-hospital mortality of pa-
tients undergoing myocardial revascularization surgery
is approximately 2.5%, and major morbidity events are
reported in 22% of cases [1]. Risk stratification plays
an important role in this type of surgery, and various
risk models are used in clinical practice. Currently, two
of the most used models are the EuroSCORE (The
European System for cardiac operative Risk Evaluation)
and STS (The Society of Thoracic Surgeons National
Cardiac Database). These models estimate postopera-
tive mortality considering patient and procedural fac-
tors; however, their application has some complexity,
and the information needed to calculate the scores is
not always available. EuroSCORE, especially, tends to
overestimate mortality [2-4]. Moreover, although sev-
eral risk factors are associated with poor prognosis
after surgery, including advanced age, preoperative
functional capacity, renal failure, diabetes mellitus,
emergency surgery, and decreased ventricular function,
these well-defined factors for increased risk are not
modifiable; consequently, there is little that can be
done to control them [5-7].
The identification of laboratory measurements or pre-
operative serum markers that are independently associ-
ated with postoperative adverse outcomes could be the
initial step in the eventual inclusion of these variables in
risk prediction models. Among these biomarkers, a
slightly lower-than-normal hemoglobin (Hb) level has
been identified as an independent predictor of poor func-
tional capacity and mortality in patients with congestive
heart failure [8]. Similarly, in coronary patients undergo-
ing percutaneous coronary intervention or cardiac sur-
gery, such biomarkers have been associated with a poor
prognosis [9,10]. Because low Hb is a potentially modifi-
able factor, its identification in patients with coronary or
valvular heart disease, or who are to undergo elective sur-
gery, would eventually help to design therapeutic regimens
designed to correct the Hb level and then assess the im-
pact of this treatment on postoperative outcomes.
Furthermore, several inflammatory markers, including
high-sensitivity C-reactive protein (hsCRP) and leukocyte
count (LEUCO), have been suggested as independent pre-
dictors of future cardiovascular risk in non-surgical pa-
tients [11,12]. Despite the important role of inflammation
in the pathophysiology of cardiovascular disease, few stud-
ies with an adequate number of patients have evaluated
the relationships of preoperative hsCRP and LEUCO
values with postoperative outcomes.
B-type natriuretic peptide (BNP) is an important prog-
nostic indicator in both heart failure and acute myocar-
dial infarction, where elevated levels identify patients at
high risk for progressive ventricular dilatation, heartfailure, or death. [13-15]. BNP is released in response to
ventricular overload and in myocardial ischemia as a re-
sult of increased wall stress [16]. The ability of BNP to
integrate the effects of various manifestations of myocar-
dial dysfunction makes it useful as an indicator of car-
diovascular prognosis in many contexts. Perioperative
BNP determination could be useful in predicting some
adverse outcomes after cardiac surgery [17,18]. These
findings are generally found in small retrospective series
and require confirmation in prospective cohorts and lar-
ger studies.
This study attempts to determine if there is an inde-
pendent association between the preoperative serum
level of Hb, LEUCO, hsCRP, or BNP and early and late
postoperative morbidity. A valuable contribution to the
preoperative evaluation could be gained by defining a
quantitative and cost-effective serum marker that shows
a demonstrated a significant independent association
with variables such as mortality and postoperative low
cardiac output (PLCO). Moreover, surgical mortality is
often analyzed as in-hospital mortality or at 30 days,
which reflects only part of the overall outcome after car-
diac surgery. Patients with complicated stays in the in-
tensive care unit (ICU) may persist with limited
functional capacity, readmissions, and shorter survival
time after being discharged, so an assessment of longer-
term morbidity and mortality could provide a more reli-
able analysis of the benefit of cardiac surgery to patients.
Methods
The study included all adult patients who underwent
elective cardiac surgery in a tertiary cardiovascular hos-
pital during a period of 18 months. Subjects who had
emergency surgery, maze surgery, atrial septal closure,
chronic obstructive pulmonary disease, any clinically im-
portant bleeding in the last 6 months, recent blood
transfusion (less than 2 weeks), or renal failure were ex-
cluded. Also excluded were patients with LEUCO <
2500 mm3 or > 30,000 mm3 or who had active infec-
tious, inflammatory, or neoplastic diseases. The reasons
for excluding these subgroups are summarized as fol-
lows: Emergency surgery is always a high-risk procedure
and would introduce difficult-to-control variables into
the study. In maze surgery, there are frequent postopera-
tive rhythm disorders, and hospital stays are usually lon-
ger; thus, many of these outcome variables would be
altered for reasons intrinsic to the surgical procedure. In
atrial septal closures, the possibility of complications is
very low, and this subgroup of patients would not pro-
vide information to the study; pulmonary disease and
chronic kidney disease alter hemoglobin, and both can
raise BNP, which are the exposure variables being evalu-
ated. Similarly, patients with diseases that could alter in-
flammatory markers were excluded.
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The cohort was distributed according to Hb, LEUCO,
hsCRP, and BNP in separate quintiles for each variable.
All patients were followed up for 12 months from the
date of surgery. Pre-specified definitions were used to
assign background or outcomes.
The primary objective was to determine whether there
is an association between the preoperative value of any of
these biomarkers and morbidity and mortality in the first
12 months postoperatively. The most important event for
the study (primary outcome) was a combination of death/
myocardial infarction/cumulative rehospitalization at 12
months postoperatively. Taking anesthetic induction as
the starting time, all clinically relevant outcomes were
recorded: postoperative bleeding requiring reoperation,
death from any cause during hospitalization, prolongation
of stay in the ICU or the hospital, number of red blood cells
transfused postoperatively, lowest postoperative Hb level,
surgical wound infection, PLCO, acute renal failure, cere-
brovascular events, atrial fibrillation (AF), ventricular tachy-
cardia or ventricular fibrillation, perioperative myocardial
infarction, and use of inotropes (over 24 hours) postopera-
tively. All events that took place from the time of hospital
discharge until the last day of the 12-month follow-up
(death from any cause, rehospitalization, acute coronary
syndrome (ACS), cerebrovascular events, or further re-
vascularization procedures or valve repair) were also
recorded. This protocol of research was presented to the
ETHICS COMMITTEE OF CLINICAL INVESTIGATION,
Instituto de Cardiología-Fundación Cardioinfantil and
approved for its execution.
Statistical methods
Because the defined primary endpoint was the estima-
tion of the significance and magnitude of the association
between each of the exposure variables and the outcome
variable, we decided that these significance values could
be ascertained by multiple regression or logistic analysis
more than by analysis of survival or time to event.
Both the differences in basic clinical characteristics be-
tween quintiles and the unadjusted relationship between
each sequence of preoperative quintiles and the specified
primary and secondary outcomes were assessed using the
trends test developed by Cuzick. Potential preoperative
confounders were included as covariates to be analyzed
using regression models of association. The association be-
tween the primary dependent variable and the independent
variables was assessed, adjusting for covariates by logistic
regression analysis. Subsequently, the association between
each of the secondary dependent variables and independ-
ent variables was assessed, adjusting for covariates.
It was modeled by means of logistic regression of associ-
ation (evaluating interaction) for dichotomous outcomes.
In the multivariate model all the covariables were includedtogether with the exposure variables in accordance with
the concept proposed by Kleinbaum [19] of which the best
model (if not the most parsimonious) is the one that con-
trols for all the confusion variables. OR and confidence in-
tervals of 95 % were calculated for each of the outcomes.
Because the sample was classified into quintiles, reported
ORs were for the expected increase in risk between the
two extreme quintiles (e.g., lowest BNP vs. highest BNP),
taking as comparator the first quintile of BNP (containing
the lowest BNP values) or the fifth quintile of Hb
(containing the highest Hb values); the second, third, and
fourth quintiles were used in the description of the raw
data and the association of each independent variable to
each of the outcomes, but not in the regression analysis.
The variables were defined as follows:
 Independent variables: Hb, LEUCO, hsCRP, and
BNP.
 Primary dependent variable: Death/MI/
rehospitalization
 Secondary dependent variables: All outcomes
described.
 Covariates: Age, left ventricular ejection fraction,
gender, diabetes mellitus, obesity, ACS in the last
month, previous cardiac surgery, type of surgery
(1 = myocardial revascularization, 2 = valve
replacement, 3 = myocardial infarction
revascularization + valve replacement with or
without an associated procedure), and use or non-
use of cardiopulmonary bypass.
A separate model excluding 16 subjects with baseline
(preoperative) Hb > 17.5 g/dL was prepared to evaluate the
hypothesis that the risk associated with Hb had a "U"
morphology in which risk also increased at high Hb values.
For all tests, p values < 0.05 were considered signifi-
cant. All analyses were performed in Stata 8.0
Results
Baseline characteristics of the cohort
A total of 559 patients were included, of whom 545 (97%)
had a complete follow-up of 12 months. See Figure 1. The
baseline characteristics of the patients are shown in
Table 1.
Tables 2, 3, 4 and 5 summarize the characteristics of
patients according to the values (distributed in quin-
tiles) of Hb, LEUCO, hsCRP, and BNP. Preoperative
Hb was lower in women (p < 0.001) and decreased
with age (p < 0.001). Patients who were residents of
cities located at an altitude of 2000-3000 m had higher
Hb (p = 0.01), and those with a history of ACS in the
last month had lower Hb (p = 0.01).
Serum hsCRP increased significantly with age (p =
0.01), the altitude of residence (p = 0.03), history of ACS
Figure 1 Flowchart.
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(p = 0.001).
Serum BNP increased significantly with age (p = 0.001),
the presence of coronary artery disease (p = 0.001), and a
history of recent ACS (p = 0.001). Serum BNP decreased
as ejection fraction increased (p = 0.001) and in obese pa-
tients (p = 0.001). LEUCO decreased with age (p = 0.01)
and in subjects residing at an altitude of 2000-3000 m
(p = 0.001).
Outcomes
Figures 2, 3, 4 and 5 show the incidence of the outcome
death/ACS/ rehospitalization from the inpatient period
and throughout the follow-up to 12 months, for each of
the variables Hb, LEUCO, hsCRP, and BNP. We ob-
served that the increases in BNP and hsCRP were asso-
ciated with adverse outcomes. For BNP, the cumulative
incidence of the composite outcome at 12 months was
20.7% in the lowest quintile, 27.9% in the secondTable 1 Baseline characteristics of the cohort (n = 554)
Age: mean ± SD 60 ±11
Age ≥ 65: n (%) 209 (37)
Males: n (%) 409 (73.8 )
Residents in a city with an altitude of
2000 - 3000 mts: n (%)
455 (82.1)
Ejection Fraction: mean % ± SD 52.1 ± 11
Diabetes Mellitus: n (%) 111 (20)
Acute Coronary Syndrome ≤ 30 days: n (%) 189 (34.1)
Obesity: n (%) 99 (17.8)
Previous Cardiac Surgery: n (%) 36 (6.5 )
Proportion of Patients undergoing CABG: n (%) 387 (69.86)
Surgery without extracorporeal circulation: n (%) 126 (22.7)quintile, 28.8% in the third quintile, 29.7% in the
fourth quintile, and 40.9% in the highest quintile (p =
0.002). The corresponding values for CRP were 21.9%,
29.7%, 30.5%, 31.5%, and 34.5% (p = 0.047). No associ-
ation with adverse outcomes was observed for the
other two variables: Hb: 32.4%, 32.6%, 32.2%, 25.9%, and
22.7% (p = 0.055); LEUCO: 28.8%, 23.6%, 31.4%, 30.6%,
and 33.6% (p = 0.22).
In-hospital mortality was 2.7% (15 subjects) (Table 6).
The crude death rate was higher in patients with higher
values of BNP and hsCRP, but these associations in the
unadjusted data were not evaluated statistically because
of the low incidence of in-hospital mortality.
A total of 109 patients (19.6%) had a PLCO (Table 6).
BNP showed a direct linear relationship with the occur-
rence of PLCO: 9.9% of subjects in the first quintile
compared with 11.7% in the second quintile, 15.3% in
the third quintile, 17.1% in the fourth quintile, and
44.5% in the fifth quintile (p = 0.0001).
The incidence of postoperative AF was 11.2% (62 pa-
tients). A linear association between preoperative BNP
concentration and the occurrence of this complication
was found: 6.3% of AF in the bottom BNP quintile vs.
20.9% in the highest quintile (p = 0.01).
The type of surgery was strongly associated with all
early outcomes; the mortality rate for group 1 (myocar-
dial revascularization) was 1.5%, 1.2% for group 2
(valve), and 17.2% for group 3 (combined procedures)
(p = 0.0001).
Analysis of the unadjusted data showed that hsCRP in-
creased significantly with age and with a history of a recent
ACS. When assessed by type of surgery, mean hsCRP was
higher in patients undergoing coronary artery bypass:
1.63 mg/L in isolated coronary revascularization, 2.29
mg/L in coronary artery bypass combined with valve
Table 2 Baseline characteristics according to preoperative hemoglobin value
Hemoglobin (g/dL) Quintile 1
(8.8–13.2)
(n = 114)
Quintile 2
(13.3-14.2)
(n =113)
Quintile 3
(14.3-15.1)
(n =118)
Quintile 4
(15.2 – 16)
(n = 108)
Quintile 5
(16.1-20.2)
(n = 101)
Trend test
Mean age (SD) 62.3 (11.9) 61.6 (10.9) 59.9 (11.2) 58.7 (9.3) 57.3 (11.9) P = 0.001
Males (%) 37.7 63.7 78.8 95.3 97.0 P = 0.001
Residents in a city with an
altitude of 2000 to 3000 m (%)
72.8 84.0 83.9 82.4 88.1 P = 0.01
Mean ejection fraction (%) 50.7 53.3 52.4 52.6 51.3 P = 0.89
Diabetes mellitus (%) 25.4 17.7 18.6 17.6 20.7 P = 0.4
Acute coronary syndrome ≤
30 days (%)
44.7 34.5 32.2 30.5 27.7 P = 0.01
Obesity (%) 14.9 17.7 16.1 20.3 20.8 P = 0.22
Previous cardiac surgery (%) 6.1 4.4 10.1 3.7 7.9 P = 0.71
Proportion of patients undergoing
CABG (%)
68.4 67.2 71.2 72.2 70.3 P = 0.09
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shown in Figure 4, when evaluating raw data, hsCRP
level exhibited a linear relationship with the primary
outcome.
The total number of transfused red blood cells (RBC)
(intraoperative + postoperative) was 1.5 units on average
(SD: 2.6), and this value showed an inverse linear associ-
ation with preoperative Hb. The number of transfused
RBC units followed a linear trend with Hb quintiles: 3.1
(SD: 3.5) for the lowest quintile, 1.7 (SD: 2.8) for the sec-
ond quintile, 1.4 (SD: 2.1) for the third quintile, 0.7 (SD:
1.3) for the fourth quintile, and 0.6 (SD: 1.6) for the
highest quintile (p = 0.0001).
The median ICU stay was 1 day (range: 1-34 days).
The duration of hospitalization for qualifying surgery
had a median of 5 days (range: 1-42 days). (Table 6).
When comparing each of these times between the first
and fifth quintiles, a statistically significant difference
(p = 0.00001) was found, and also for the comparisons
between extreme Hb quintiles and the length of ICUTable 3 Baseline characteristics according to preoperative B-t
B-type natriuretic peptide Quintile 1
(0 - 25.2)
(n = 111)
Quintile 2
(25.3 – 53.6
(n =111)
Mean age (SD) 59.0 (9.7) 57.5 (11.4)
Males (%) 78.3 76.5
Residents in a city with an altitude of
2000- 3000 m (%)
85.6 81.0
Mean ejection fraction (%) 54.0 (9.2) 53.8 (11.3)
Diabetes mellitus (%) 23.4 18.9
Acute coronary syndrome ≤ 30 days (%) 14.4 35.1
Obesity (%) 25.2 16.2
Previous cardiac surgery (%) 5.4 6.3
Proportion of patients undergoing CABG (%) 72.9 79.2stay (p = 0.002) and length of hospital stay (p =
0.0088). There was no association between these
dependent variables and inflammatory markers, hsCRP
(p = 0.46), or LEUCO (p = 0.98)
Nonparametric tests showed an unadjusted significant
association between high BNP (fifth quintile) and total
RBC units transfused in the perioperative period (p =
0.0001), and between low hemoglobin (first quintile) and
total RBC units transfused perioperatively (p = 0.00001).
There was no association between red blood cells units
and LEUCO (p = 0.29) or hsCRP (p = 0.63).
Follow-up through 12 months was achieved in 98.4%
of the patients. During this time, 164 primary endpoint
events occurred in 107 subjects (cumulative death/ACS/
reshopitalization) Cumulative overall mortality at 12
months was 4.15%. The raw data showed a direct linear
relationship between each of these factors and the out-
come: p = 0.001 for Hb, p = 0.01 for BNP, p = 0.03 for
WBC, and p = 0.09 for hsCRP. There were 143
rehospitalization events (25.81%). A significant, directype natriuretic peptide
)
Quintile 3
(53.7 – 108.3)
(n =111)
Quintile 4
(109.2 – 240.4)
(n = 111)
Quintile 5
(258 - 4000)
(n = 110)
Trend test
60.8 (12.1) 61.2 (11.3) 61.5 (11.0) P=0.001
71.1 68.4 74.5 P = 0.23
80.1 81.0 82.7 P = 0.64
54.2 (11.1) 51.2 (11.0) 45.1 (12.7) P = 0.001
15.3 17.1 25.4 P = 0.86
31.5 42.3 47.2 P = 0.001
19.8 17.1 10.9 P = 0.02
8.1 5.4 7.2 P = 0.7
68.4 71.1 57.2 P = 0.001
Table 4 Baseline characteristics according to preoperative high-sensivity c-reactive protein
Hs C-reactive protein Quintile 1
(0.02 - 0.19)
(n = 114)
Quintile 2
(0.2 – 0.42 )
(n =111)
Quintile 3
(0.43 – 0.78)
(n =108)
Quintile 4
( 0.79 – 2.14)
(n = 111)
Quintile 5
(2.15 - 16)
(n = 110)
Trend test
Mean age (SD) 58.7 (11.3) 57.9 (12.5) 60.1 (10.9) 61.4 (9.7) 61.9 (10.8) P = 0.01
Males (%) 74.5 71.1 68.5 78.3 76.3 P = 0.42
Residents in a city with an
altitude of 2000- 3000 m (%)
75.4 79.2 87.9 81.9 86.3 P = 0.03
Mean ejection fraction (%) 51.8 (12.3) 54.9 (11.1) 52.3 (11.9) 50.7 (11.5) 50.7 (11.5) P = 0.06
Diabetes mellitus (%) 19.3 22.5 20.3 19.8 18.1 P = 0.69
Acute coronary syndrome ≤
30 days (%)
10.5 18.9 30.5 51.3 60.0 P < 0.001
Obesity (%) 11.4 23.4 22.2 19.8 12.7 P = 0.96
Previous cardiac surgery (%) 7.0 9.9 6.4 6.3 2.7 P = 0.10
Proportion of patients
undergoing CABG (%)
59.6 62.1 72.2 77.4 78.1 P < 0.001
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BNP level (p = 0.01).Multivariate analysis
After adjustment for all covariates described, the ORs
for all primary and leading secondary outcomes are
shown in Tables 7, 8, 9, 10 and 11. The highest quintile
(or lowest in the case of Hb) was used as a comparator
for all regression analyses. The reported ORs refer to
comparisons with the first quintile (or fifth in the case of
Hb). The specific values of the quintiles for each variable
are described in Tables 2, 3, 4 and 5.Hemoglobin
The OR for the composite primary outcome at 12
months was 0.88 p = 0.72 (95% CI 0.43-1.78). The ad-
justed OR for in-hospital mortality was 0.9 (95% CI
0.24–3.30) and for 12-month mortality was 0.20 (95% CI
0.02–1.89). Preoperative Hb level was significantly andTable 5 Baseline characteristics according to preoperative leu
Leukocyte couNT Quintile 1
(3100 – 5600)
(n = 111)
Quintile 2
(5620 – 65
(n =114)
Mean age (SD) 61.7 (11.2) 60.6 (11.5)
Males (%) 67.5 71.9
Residents in a city with an altitude of
2000- 3000 m (%)
90 85.9
Mean ejection fraction (%) 53.3 (10.3) 52.9 (11.8)
Diabetes mellitus (%) 19.8 15.8
Acute coronary syndrome ≤ 30 days (%) 42.3 26.3
Obesity (%) 15.3 14.0
Previous cardiac surgery (%) 5.4 7.0
Proportion of patients undergoing CABG (%) 69.3 62.2independently associated with the occurrence of PLCO
(OR 0.33, 95% CI 0.13–0.81, p = 0.016).
The occurrence of postoperative ventricular tachycar-
dia was highly related to in-hospital mortality; mortality
in the group that suffered this condition was 18.7% vs.
2.2% in the group without this arrhythmia (p = 0.0001).
Preoperative Hb showed a marginal association with the
emergence of VT, with an estimated OR of 0.10 (95% CI
0.01–1.10). Other outcomes were rare and showed no
statistically significant association with mortality.
Separate analysis of patients with Hb > 17.5 g/dL
found no evidence of increased risk in this subgroup of
patients.
Leukocyte count
There was no significant independent association between
LEUCO and any of the variables studied. The adjusted OR
for the primary outcome was 1.41 (95% CI 0.78–2.55), for
in-hospital mortality 3.19 (95% CI 0.47–21.5), and mortal-
ity at 12 months 3.73 (95% CI 0.88–15.85). For cumulativekocyte count
00)
Quintile 3
(6510 – 7320)
(n =108)
Quintile 4
(7370 – 8580)
(n = 111)
Quintile 5
(8590 – 16200)
(n = 110)
Trend test
59.5 (11.4) 59.8 (11.0) 58.4 (10.7) P = 0.01
79.6 77.4 72.7 P = 0.23
85.2 74.7 74.5 P < 0.001
52.4 (11.4) 50.2 (12.6) 51.6 (12.1) P = 0.2
17.8 18.9 28.2 P = 0.10
32.4 34.2 35.4 P = 0.69
23.1 18.9 18.1 P = 0.35
7.4 5.4 7.2 P = 0.78
67.6 72.9 77.2 P = 0.07
Figure 2 Cumulative incidence of the combined outcome (death/ACS/rehospitalization) for hemoglobin quintiles through 12 months.
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CI 0.64–2.18). The association between LEUCO and
cumulative ACS at 12 months had an OR of 1.62 (95%
CI 0.56–4.72).
High-sensitivity CRP
hsCRP had no significant independent association with
any of the variables studied. The OR for the composite
primary outcome at 12 months was 1.53 (95% CI 0.80–
2.91). The adjusted OR for in-hospital mortality was 2.1
(95% CI 0.20 – 21.96) and for 12-month mortality was
3.28 (95% CI 0.34–31.7). For cumulative rehospitalization
at 12 months, the OR was 1.43 (95% CI 0.73–2.76). For
cumulative ACS at 12 months, the OR was 2.33 (95% CI
0.66–8.28). hsCRP also had no independent significant as-
sociation with other outcome variables, such as PLCO,
AF, cerebrovascular events, ventricular tachycardia, and
acute renal failure.Figure 3 Cumulative incidence of the combined outcome (death/ACS
through 12 months.B-type natriuretic peptide
The OR for the association between BNP and the com-
posite primary outcome at 12 months was 1.93 (95% CI
1.00–3.74). However, a significant interaction was found
between the level of BNP and the presence or absence of
diabetes. The OR for non-diabetic subjects was 1.26
(95% CI 0.61–2.60), but for diabetics the OR was 18.82
(95% CI 16.2–20.5). Tables 10 and 11. For cumulative
rehospitalization within 12 months, an OR of 1.21 (95%
CI 0.57–2.56) was obtained for non-diabetics, while for
diabetics the OR was 18.7 (95% CI 16.5–20.8). The inter-
action BNP x diabetes mellitus could not be evaluated
for other secondary outcomes due to lack of sufficient
observations at each level of interaction.
Regarding BNP and atrial fibrillation, the adjusted OR
was 3.88 (95% CI 1.45–10.38). Equally significant was
the risk related to the occurrence of postoperative low
cardiac output, with an OR of 3.46 (95% CI 1.53–7.80,/rehospitalization) for B-Type Natriuretic Peptide (BNP) quintiles
Figure 4 Cumulative incidence of the combined outcome (death/ACS/ rehospitalization) for hs C-Reactive Protein (hs-CRP) quintiles
through 12 months.
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association.
Discussion
Our results show that high BNP is an important pre-
dictor of early and late postoperative complications. The
OR adjusted for postoperative atrial fibrillation was 3.8
(95% CI 1.45–10.38). Several risk factors are associated
with the occurrence of atrial fibrillation after cardiac sur-
gery; they include mainly old age, low ejection fraction,
and heart valve surgery. The onset of this arrhythmia is
most likely a consequence of hemodynamic, electrical,
and histological atrial tissue abnormalities related to
intraoperative changes [20,21] and is associated with a
higher incidence of early complications, such as congest-
ive heart failure, stroke, renal dysfunction, infections,
and neurocognitive impairment [22]. Postoperative atrial
fibrillation increases hospital stays and health care costs
[22,23], so strategies to predict its occurrence may haveFigure 5 Cumulative incidence of the combined outcome (death/ACS
12 months.important clinical and economic relevance by intensify-
ing preoperative medical treatment, enabling the use of
perioperative intensive prophylaxis schemes, or eventually
leading to the use of intraoperative ablation techniques.
These advancements could decrease the incidence of
adverse events in this high-risk group and reduce hos-
pital stay, costs, and morbidity associated with atrial
fibrillation [24].
The incidence of atrial fibrillation in our group was
11.2%, which is not as high as that reported in other series
[22-24]; however, several subgroups at high risk for this
complication had to be excluded. During their stay at gen-
eral ward hospitalization it is also possible that some pa-
tients had transient episodes of atrial fibrillation that were
not documented. This lack of detection, however, would
suggest that these events did not have clinical significance.
The risk attributable to elevated BNP (cutoff for the
top quintile: 258 pg/mL) in our group is very similar to
that reported in the Cleveland Clinic series [25] that/rehospitalization) for white blood cell count quintiles through
Table 6 Inhospital outcomes (n = 554)
Overall mortality. n(%) 15 (2.7)
Surgical reintervention. n(%) 39 (7)
Postoperative low cardiac output (PLCO). n(%) 109 (19.6)
Postoperative acute renal failure. n(%) 8 (1.4)
Stroke. n(%) 13 (2.3)
Perioperatory Acute Myocardial Infarction. n(%) 9 (1.6)
Postoperative Atrial Fibrillation. n(%) 62 (11.2)
Postoperative Ventricular Tachycardia. n(%) 16 (2.9)
Intensive Care Unit (ICU) stay (days). Median (range) 1 (1-34)
Hospital stay (days). Median (range) 5 (1-42)
Units of transfused red blood cells (RBC)
(intra + post-operative). mean (SD)
1.5 (SD: 2.6)
Lowest postoperative hemoglobin value. mean (SD) 10.4 (SD: 1.4)
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records were retrospectively evaluated, revealing an OR
of 3.7 when comparing the highest with the lowest quar-
tile. Our data also show that preoperative BNP measure-
ment is valuable in predicting a significant increase in
the probability of postoperative low cardiac output: OR
3.46 (95% CI 1.53–7.80); in turn, this complication is
closely related to the overall morbidity and mortality
[26]. The ability to anticipate the need for prolonged
postoperative myocardial inotropy has important clinical
implications, as the measurement of BNP can be used to
identify patients who require intensive preoperative
medical therapy. Additionally, a common problem in
practice is to define the appropriate time to carry out
cardiac surgery in patients who require complex proce-
dures; perhaps BNP measurement could be useful in
these patients. In this series, other unadjusted postopera-
tive outcomes were also significantly related to high
BNP: hospital stay, ICU stay, and number of transfused
RBC units; each of these has been associated with in-
creased postoperative morbidity and mortality. Our re-
sults open the possibilities of designing research studies
that incorporate BNP measurement as a routine part of
the preoperative evaluation and comparing this strategy
with the standard evaluation, in terms of reducing post-
operative adverse events.Table 7 Multivariate hemoglobin analysis
Outcomes Adjusted OR 95% CI
Primary (death/ACS/rehospitalization
through 12 months)
0.88 0.43 – 1.78
Atrial fibrillation 0.75 0.28 – 2.01
Perioperatory stroke 0.45 0.038 – 5.29
Reintervention required 0.86 0.28 – 2.62
Low cardiac output syndrome 0.33 0.13 – 0.81
Ventricular tachycardia 0.10 0.01 – 1.10Regarding late events, for the pre-specified primary
outcome, a significant interaction was found between
BNP and diabetes, with a significant increase in risk
when BNP was elevated in diabetic subjects. This in-
crease in risk among diabetic subjects with elevated BNP
is most likely multifactorial in origin. Elevated BNP in
diabetic subjects, with or without microalbuminuria,
could represent the presence of an early stage of dia-
betic nephropathy, in which the level of creatinine is
not yet affected [27,28]. It is possible that even mild
degrees of renal dysfunction significantly impact post-
operative morbidity. In the Steno-2 study of 160 type 2
diabetic subjects with microalbuminuria, higher base-
line N-terminal-proBNP was associated with longer
duration of diabetes, older age, higher systolic blood
pressure, and impaired kidney function [29]. In our
series, although diabetics tended to have higher morbidity
and mortality at 12 months (primary outcome variable:
31.5% in diabetics vs. 29.1% in non-diabetics), this differ-
ence was not statistically significant. However, subjects
with diabetes had other conditions associated with risk:
older age (63.9 years vs. 59.0 years, p = 0.0001) and lower
ejection fraction (50.0% vs. 52.6%, p = 0.017). These data
could indicate that the subgroup of diabetic patients with
elevated BNP have a higher comorbidity, which might ex-
plain our results. Moreover, diabetic heart disease is asso-
ciated with a range of morphological changes, including
myocyte hypertrophy, perivascular fibrosis, and accumula-
tion of extracellular matrix amorphous protein. Over time,
these processes contribute to the development of left ven-
tricular hypertrophy, coronary artery disease, and congest-
ive heart failure, each of which is associated with elevated
BNP. Even if the ejection fraction is normal, occult cardio-
myopathy characterized by impaired relaxation and a stiff
left ventricle may precede manifestations of heart disease
in patients with diabetes [30].
Finally, the hidden causes of nephropathy and more
advanced heart disease may not be the only reason ele-
vated BNP is associated with a significant increase in
postoperative risk; other factors may include hyperten-
sion, increased extracellular volume, and pulmonary
hypertension. Because all of these can be considered
markers of cardiac risk, it is clear that the non-specific
elevation of BNP can provide a useful indication of over-
all cardiovascular risk in this population.
Our data do not confirm that inflammatory markers
were significantly and independently associated with the
assessed outcomes; for hsCRP, the composite outcome
had an OR of 1.53 (95% CI 0.80–2.91). For the same out-
come, LEUCO had an OR of 1.41 (95% CI 0.78–2.55).
In a retrospective review of 720 patients undergoing
cardiac surgery, where a measure of hsCRP was avail-
able, Cappabianca et al. identified that CRP ≥ 0.5 mg/dL
conferred a higher risk of in-hospital mortality and
Table 8 Multivariate leukocyte count analysis
Outcomes Adjusted OR 95% IC
Primary (death/ACS/rehospitalization
through 12 months)
1.41 0.78 – 2.55
Atrial fibrillation 1.19 0.50 – 2.81
Perioperatory stroke 1.19 0.15 – 9.04
Reintervention required 0.81 0.25 – 2.58
Low cardiac output syndrome 0.73 0.35 – 1.51
Ventricular tachycardia 0.80 0.22 – 2.89
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ating retrospectively a subgroup of 87 patients with cor-
onary revascularization, found that in patients with
hsCRP above the median (1.9 mg/L), the cumulative in-
cidence of cardiovascular events with a follow-up at 7.3
years was 29%, compared with 9% in patients with levels
below the median (p = 0.048), independent of other risk
factors [32]. However, Gaudino et al., in a prospective study
of 114 patients undergoing myocardial revascularization
surgery, found that CRP > 5 mg/L did not predict in-
hospital postoperative complications or influence the extent
of inflammatory activation [33]. In a larger series, Biancari
et al. reported that preoperative CRP ≥ 1.0 mg/dL carried a
higher overall risk of global postoperative death (5.3% vs.
1.1%, p = 0.001), cardiac death (4.4% vs. 0.8%, p = 0.002),
and low cardiac output syndrome (8.8% vs. 3.7%, p = 0.01)
(47). Ahlsson [34] found no association between preopera-
tive CRP and postoperative atrial fibrillation.
The discrepant findings in the above results could sug-
gest that multiple underlying risk factors are involved in
the associations between adverse postoperative outcomes
and hsCRP level. Insufficient adjustment for confounding
variables related to the load of comorbidities may lead to
an overestimation of risk. In our series, we carefully con-
trolled for confounders by excluding active infectious and
inflammatory or neoplastic processes. Furthermore, in
multivariate analysis, age, gender, ejection fraction,
diabetes mellitus, recent ACS, obesity, previous cardiacTable 9 Multivariate high-sensivity CRP analysis
Outcomes Ajusted OR 95% IC
Primary (death/ACS/rehospitalization
through 12 months)
1.53 0.80 – 2.91
Atrial fibrillation 0.76 0.31 – 1.89
Perioperatory stroke 0.26 0.033 – 2.09
Reintervention required 0.72 0.20 – 2.57
Low cardiac output syndrome 1.55 0.73 – 3.30
Ventricular tachycardia 2.26 0.15 – 33.28
Primary (death/ACS/rehospitalization
through 12 months)
1.23 0.24 – 6.17surgery, using or not using cardiopulmonary bypass,
and type of surgery were controlled. It is possible that
the relationship between preoperative and postopera-
tive outcomes of hsCRP can largely be explained by
multiple underlying factors that elevate hsCRP and in-
crease surgical risk. However, because the ORs that we
found for most of the outcomes were close to 1.5 for
hsCRP throughout the follow-up, it is also possible
that the sample size was insufficient to determine a
real association.
Lower preoperative Hb was associated with increased
postoperative adverse events in a Hb dose-dependent
manner. A lower preoperative Hb (below 13.2 g/dL) was
associated with increased in-hospital mortality and at 12
months and more likely to require inotropic drugs and
suffer acute renal failure, cerebrovascular events, high-
grade ventricular arrhythmias, and require RBC transfu-
sion in the postoperative period. The primary composite
outcome was also more frequently observed in the
presence of lower Hb. Some pre-specified outcomes
occurred entirely or almost entirely in the lowest
hemoglobin quintiles (in-hospital mortality, acute renal
failure, cerebrovascular events, and ventricular tachy-
cardia); given their rarity and the fact that outcomes
were concentrated in only one or two quintiles, we
not considered it appropriate to test for statistical
significance.
The effect of low Hb on most of the outcomes was at-
tenuated after adjustment for the described covariates.
However, the independent relationship between the low-
est Hb values and postoperative low cardiac output was
not affected by adjusting for covariates, yielding an OR
of 0.33 (95% CI 0.13–0.81). A significant association was
found between low preoperative Hb and major postoper-
ative outcomes: hospital stay, ICU stay, and number of
units of RBCs transfused. As mentioned above, these
variables are associated with postoperative morbidity
and mortality.
Reduced Hb may contribute to worse outcomes
through a higher peripheral and myocardial oxygen de-
mand and development of left ventricular hypertrophy,
mainly due to a secondary increased cardiac output [35].
An inverse relationship between Hb value and left ven-
tricular hypertrophy has been reported in clinical studies
of patients with chronic kidney disease [36]. In a subgroup
of patients with chronic heart failure, an increase of 1 g/dL
in Hb was associated with a decrease of 4.1 g/m2 in left
ventricular mass in a 24-week follow-up [37]. These
changes could explain the increased risk of arrhythmias
and the occurrence of low cardiac output in our patients
with low Hb.
Our results show that the need for RBC transfusion in
the perioperative period is directly related to the value of
preoperative Hb, even in the absence of a defined
Table 10 Type-b natriuretic peptide interaction with diabetes mellitus (multivariate analysis)
Outcomes Adjusted OR DM (-) 95% CI Adjusted OR DM (+) 95% CI
Primary (death/ACS/rehospitalization through 12 months) 1.26 0.61–2.61 18.8 16.2 – 20.5
Rehospitalization through 12 months 1.21 0.57–2.56 18.7 16.5 – 20.8
Hernández-Leiva et al. Journal of Cardiothoracic Surgery 2013, 8:170 Page 11 of 13
http://www.cardiothoracicsurgery.org/content/8/1/170anemia; subjects with Hb < 13.2 g/dL required an aver-
age transfusion of 3.1 units of RBCs, while if hemoglobin
was > 16.1 g/dL, the required RBC units dropped to 0.6.
One study showed that both preoperative anemia and
intraoperative transfusion of red cells were independent
and additive factors for adverse outcomes. Patients with
low preoperative Hb had a higher incidence of postoper-
ative adverse events, but for the same level of Hb, the
risk of postoperative complications increased signifi-
cantly with RBC transfusion. In addition, they observed
a direct relationship between the number of RBC units
transfused intraoperatively and the incidence of adverse
events [38]. This independent association between RBC
transfusion and adverse outcomes has been repeatedly
described [39-44].
In this series, the fact that polycythemic subjects were
at higher risk of postoperative adverse events could not
be confirmed. However, this is physiologically plausible,
and the number of subjects with this feature in the sam-
ple was low (16 patients); thus, it cannot be concluded
that there was no such association.
Our findings open the possibility of designing random-
ized studies to assess if the optimization of preoperative
Hb concentration, through the use of erythropoietin
and/or iron therapy, would reduce perioperative transfu-
sion and the incidence of ventricular arrhythmia, acute
renal failure, and postoperative low cardiac output.Limitations
Although the sample size was calculated to detect an in-
crease in risk by a factor of 2 for the variable Hb, the
study may have been underpowered to detect the prog-
nostic significance of hsCRP and LEUCO, most likely
because inflammatory mechanisms are a weaker pre-
dictor of outcomes than Hb or BNP. The ORs found
were slightly above 1.5; multicenter studies on a larger
scale would be needed to achieve the required precision.Table 11 Type-b natriuretic peptide (multivariate
analysis)
Outcomes OR adjusted 95% IC
Atrial fibrillation 3.80 1.45 – 10.38
Perioperatory cerebrovascular event 1.96 0.18 – 21.40
Need for reintervention 0.88 0.31 – 2.49
Low cardiac output syndrome 3.46 1.53 – 7.80
Ventricular tachycardia 1.74 0.34 – 8.82The incidence of atrial fibrillation may have been
underestimated because continuous electrocardiogram
monitoring is not routinely performed in postoperative
patients after they are discharged from the ICU. There-
fore, some patients may have had transient episodes of
During their stay at general ward hospitalization. This
lack of detection, however, would suggest that these
events did not have clinical significance.
This study required multiple statistical analyses to as-
sess the independent effects of four biomarkers on sev-
eral postoperative outcomes. However, this does not
increase the possibility of a type I error because the ana-
lysis of the data sets for each independent variable was
done separately and all hypotheses were pre-specified.
Conclusions
Our study reveals important risk factors that could help
stratify patients undergoing heart surgery. Elevated BNP
(top quintile: > 258 pg/mL) was independently associ-
ated with several adverse postoperative outcomes, espe-
cially atrial fibrillation, postoperative low cardiac output,
and rehospitalization in the first year; the risk increased
significantly in patients with diabetes mellitus. Low Hb
(a dose-dependent effect for any value < 16.1 g/dL) was
independently associated with the occurrence of postop-
erative low cardiac output.
Further studies are required to assess whether Hb or
BNP level provides prognostic information in addition
to the existing methods in terms of improving the pre-
diction of postoperative adverse outcomes. The inclusion
of these variables in risk stratification schemes could re-
duce morbidity and mortality, including hospital stay
and costs of care.
Definitions
Prespecified Definitions were used to assign precedents
or outcomes, this way:
* Ejection Fraction of the left ventricle (EF): The last
reported value of EF (before the surgery) in the echocar-
diogram or the left ventriculogram of each patient.
When discrepancy was found in the result of these ex-
aminations, the EF was taken from the last of any of the
two, before the surgery.
• Previous cardiac surgery: It is defined this way, if
for the qualifying surgery (or current) there is the prece-
dent in any stage of open heart surgery for any reason.
• Reintervention due to bleeding: New cardiac sur-
gery, in the intrahospitalary period, after the accomplished
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or excessive bleeding.
Diabetes mellitus: Any of the following situations: 1)
A casual preoperative glicemia the same or greater to
200 mg/dl (11.1 mmol/l), glicemia in preoperative fasting
same or grater to 126 mg/dl (7 mmol/l), 2) Regular in-
gestion of oral hypoglycemiants or regular application of
insulin. 3) Previous diagnosis of diabetes mellitus carried
out by a physician.
• Obesity: Body Mass Index> 30 Kg/m2
• Surgical wound Infection: Presence of inflamma-
tory signs in the surgical wound associated with secre-
tion in which bacterial growth is recorded.
• Chronic pulmonary disease: Diagnosis of Chronic
Obstructive Pulmonary Disease (COPD) carried out by a
physician and confirmed with espirometry which dem-
onstrates a relation VEF1/CVF <70 % of what was pre-
dicted or findings on the thorax x-ray compatible with
COPD symptoms of chronic cough and/or dyspnea.
• Perioperatory acute myocardial Infarction (AMI):
It refers to the AMI inside a 30 day postoperative (POP)
period. Since the most frequent incidence is during the
first hours of POP, in this period it is defined as the Seg-
ment Elevation located from ST in the EKG POP immedi-
ately followed by enzymatic elevation (Mb> 5 times upper
limit and/or troponin I> 10 ng/dL at 12 hours of POP).
Between the 3rd and 30th day POP, the diagnosis is identi-
cal to the one described in the following numeral (postop-
erative acute myocardial Infarction). Intubated Patients or
with mental or neurological alteration that makes the
evaluation of symptoms difficult, will be evaluated by a
group of experts different from the investigators, to define
if there is or not an AMI criteria.
• Postoperative acute myocardial Infarction: It re-
fers to the AMI after the 30th postoperative day. It is de-
fined as: Curve of ascent and descent of (Troponin I or
T) biochemical markers of myocardial necrosis, with at
least one of the following: Ischemic symptoms, patho-
logical Q-wave development in the EKG, indicative EKG
changes of ischemia (elevation or depression of ST
segment).
• Use of inotropes for more than 24 hours in post-
operative (Postoperative low cardiac output): It refers
to any inotrope administered intravenously in continu-
ous infusion for more than 24 hours. For the specific
case of Dopamine this criteria was considered to be
positive if the dose was greater than 3 mc/Kg/min.
• Acute Renal insufficiency: Elevation of creatinine
to values greater than 2 mgs/dL or increments of more
than 1.5 mgs in regards to the preoperative value.
• Cerebrovascular Event: New neurological deficit,
transitory or permanent, global or focal, with a duration
of more than 24 hours and evidence of ischemic area in
a cerebral computerized axial tomography (cerebralTAC) or magnetic resonance imaging (MRI). Psycho-
motor Deficits or patients diagnosed as "delirium", “
confussion” “ or “ demencia “ are not considered to have
neurological deficit unless a neurological focal deficit is
present.
• Postoperative Atrial Fibrillation: It was defined as
an absence of P wave before QRS complexes together
with irregular ventricular rhythm. A 12- Lead electrocar-
diogram was practiced to confirm the diagnosis.
• Postoperative Ventricular Tachycardia: 3 or more
electrocardiographic beats of wide complex in the
intrahospitalary follow up by means of continuous tel-
emetry in the ICU.
• Type of surgery: 3 groups were considered: Group 1
formed by the myocardial revascularization surgery
(CABG); Group 2, valvular substitution or repair sur-
gery; Group 3 or combined, includes CABG related with
valvular surgery with or without additional procedures,
including ventricular restoration, surgery on 2 or 3
valves, ascending aorta replacement, etc.
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